All the 10,823 persons from Karnataka stranded in other countries, who will be arriving in the State from May 8, will be quarantined and compulsorily

The latest bottleneck to confront the Indian healthcare system in scaling up molecular diagnostic testing for Covid-19 is shortage of tools and equipment needed to collect and transport samples called the viral transport mediums (VTM).

India continues to see a shortfall in the availability of personal protection equipment (PPE) for healthcare even as the government significantly ramps up domestic production and some kits from China failed quality tests.

A Kerala-based institute has developed a diagnostic test for Covid-19 which it claims can furnish results in less than half the time taken by the method currently being used in the country and for a fraction of its cost — ₹1,000.

These kits, also known as serological testing kits, are not meant for early diagnosis or detection of the disease, said Raman Gangakhedkar, head of the department of epidemiology at the Indian Council of Medical Research.

The Indian Council of Medical Research on Tuesday advised states not to use the new rapid antibody test for Covid-19 from China till further notice after reports emerged that the kits are faulty. “The kits will be tested and validated in the field by our teams.

The department of biotechnology has granted funds to 16 companies for developing drugs, vaccines and devices to fight the Covid-19 pandemic as India looks to speed up the process of tackling the disease.

The Indian Council of Medical Research has started analysing results from the evaluation of antibody test kits imported from China and will come out with its conclusions on their efficacy early next week, a senior government official told ET.

The EIR has been closed with a voluntary action indicated (VAI) classification for the observations, it added. As per the USFDA, a VAI means that objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.

This programme brings together academia — National Centre for Cell Science, Indian Institute of Technology, Indore, and industry – PredOmix Technologies and Bharat Biotech, in a collaborative mode for a public health emergency.

China said Friday it supports a World Health Organization-led review into the global response to the coronavirus outbreak, but only “after the pandem

The coronavirus' constant mutation is unlikely to have changes its potency or its contagiousness, disease experts say, despite recent research sugge

Mullah Akhtar Mansour was killed in a drone strike in 2016

Mr. Johnson is due to announce the next steps in Britain’s battle to tackle the novel coronavirus following a review by ministers of the current measures

The move is likely to benefit a large number of Indian nurses and doctors, who are either on H-1B or J2 visas.

A select list of stories to read before you start your day

The company, which entered Indian market last year with 10 models, expanded its product range to 12 models with the launch of Thunderbird LT.

The board of directors of the company will meet at a 15th century heritage villa in the capital city of the Italian region of Tuscany.

“Sri Lanka has been a very big market for us. In recent times, we have seen some large volumes out of that market,” Munjal told ET on Monday.

Transport department has agreed to register new models of two-wheelers compliant with BS-III emission norms launched in the capital prior to April 1.

"XPulse (concept) that we showed today is in that (premium) segment. There are other products that are under development currently," Munjal said.

The National Mission for Clean Ganga (NMCG), an arm of the Jal Shakti Ministry that deal with the rejuvenation programme for the river, had received a number of proposals, including from people and NGOs working on Ganga, to undertake clinical studies for treatment of coronavirus patients with the water, officials said.

New Delhi [India], May 7 (ANI) As per the modeling data and the way India's COVID-19 cases are increasing, it is likely that peak can come in June and July, said AIIMS-Delhi Director Dr Randeep Guleria on Thursday.

Carlyle is expected to first buy around 50% stake from the promoters and their families at Rs 85-90 a share, or a 7-10% premium to the current market price, and then launch an open offer to the minority investors.

The ministry asserted that if dos and don'ts are followed, the peak in number of COVID-19 cases can be avoided.

The bacille Calmette-Gurin (BCG) vaccine has a documented protective effect against meningitis and disseminated TB in children, according to the World Health Organisation. It is part of the mandatory childhood immunization programme in many countries including India.

Though hospitals have resorted to e-consultations, the increased burden to create capacity to deal with the Covid-19 situation has resulted in huge losses.